The Bioprocessing Summit 2020

We’re presenting at the 12th Annual Bioprocessing Summit, which will be held virtually from Aug 24-28, 2020.

Presentation

Track: Gene Therapy Manufacturing
Friday, Aug 28
12:20-12:40pm ET

Jacob Smith, PhD, Director, Process Development
Advances in rAAV Manufacturing: Vertical Integration and Continuous Process Improvement

Recombinant adeno-associated virus (rAAV) has emerged as a dominant gene-delivery vector of choice. Despite numerous advances in the clinic, the efficiency and cost of producing rAAV drug product to meet a rapidly growing industry has significant room for improvement. RhiaPharmaceutical has developed a model for advancing multiple clinical programs, with an emphasis on establishing early benchmarks in manufacturing feasibility, while focusing on continuous process development and improvements to large-scale manufacturing.